By delineating how HPV utilizes circE7 to induce epigenetic reprogramming that facilitates immune evasion in HNSCC, this work proposes a novel therapeutic strategy: combining anti-PD-1 and anti-TIM-3 inhibitors to counteract this immunosuppressive axis. The gene discussed is HAVCR2; the disease is head and neck squamous cell carcinoma.